Cargando…

Ligand and Structure-Based Approaches for the Identification of Peptide Deformylase Inhibitors as Antibacterial Drugs

Peptide deformylase (PDF) is a metalloprotease catalyzing the removal of a formyl group from newly synthesized proteins, which makes it an important antibacterial drug target. Given the importance of PDF inhibitors like actinonin in antibacterial drug discovery, several reported potent PDF inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Jian, Liang, Li, Zhu, Yasheng, Qiu, Shengzhi, Wang, Tao, Zhang, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964514/
https://www.ncbi.nlm.nih.gov/pubmed/27428963
http://dx.doi.org/10.3390/ijms17071141
_version_ 1782445127666499584
author Gao, Jian
Liang, Li
Zhu, Yasheng
Qiu, Shengzhi
Wang, Tao
Zhang, Ling
author_facet Gao, Jian
Liang, Li
Zhu, Yasheng
Qiu, Shengzhi
Wang, Tao
Zhang, Ling
author_sort Gao, Jian
collection PubMed
description Peptide deformylase (PDF) is a metalloprotease catalyzing the removal of a formyl group from newly synthesized proteins, which makes it an important antibacterial drug target. Given the importance of PDF inhibitors like actinonin in antibacterial drug discovery, several reported potent PDF inhibitors were used to develop pharmacophore models using the Galahad module of Sybyl 7.1 software. Generated pharmacophore models were composed of two donor atom centers, four acceptor atom centers and two hydrophobic groups. Model-1 was screened against the Zinc database and several compounds were retrieved as hits. Compounds with Qfit values of more than 60 were employed to perform a molecular docking study with the receptor Escherichia coli PDF, then compounds with docking score values of more than 6 were used to predict the in silico pharmacokinetic and toxicity risk via OSIRIS property explorer. Two known PDF inhibitors were also used to perform a molecular docking study with E. coli PDF as reference molecules. The results of the molecular docking study were validated by reproducing the crystal structure of actinonin. Molecular docking and in silico pharmacokinetic and toxicity prediction studies suggested that ZINC08740166 has a relatively high docking score of 7.44 and a drug score of 0.78.
format Online
Article
Text
id pubmed-4964514
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-49645142016-08-03 Ligand and Structure-Based Approaches for the Identification of Peptide Deformylase Inhibitors as Antibacterial Drugs Gao, Jian Liang, Li Zhu, Yasheng Qiu, Shengzhi Wang, Tao Zhang, Ling Int J Mol Sci Article Peptide deformylase (PDF) is a metalloprotease catalyzing the removal of a formyl group from newly synthesized proteins, which makes it an important antibacterial drug target. Given the importance of PDF inhibitors like actinonin in antibacterial drug discovery, several reported potent PDF inhibitors were used to develop pharmacophore models using the Galahad module of Sybyl 7.1 software. Generated pharmacophore models were composed of two donor atom centers, four acceptor atom centers and two hydrophobic groups. Model-1 was screened against the Zinc database and several compounds were retrieved as hits. Compounds with Qfit values of more than 60 were employed to perform a molecular docking study with the receptor Escherichia coli PDF, then compounds with docking score values of more than 6 were used to predict the in silico pharmacokinetic and toxicity risk via OSIRIS property explorer. Two known PDF inhibitors were also used to perform a molecular docking study with E. coli PDF as reference molecules. The results of the molecular docking study were validated by reproducing the crystal structure of actinonin. Molecular docking and in silico pharmacokinetic and toxicity prediction studies suggested that ZINC08740166 has a relatively high docking score of 7.44 and a drug score of 0.78. MDPI 2016-07-15 /pmc/articles/PMC4964514/ /pubmed/27428963 http://dx.doi.org/10.3390/ijms17071141 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Gao, Jian
Liang, Li
Zhu, Yasheng
Qiu, Shengzhi
Wang, Tao
Zhang, Ling
Ligand and Structure-Based Approaches for the Identification of Peptide Deformylase Inhibitors as Antibacterial Drugs
title Ligand and Structure-Based Approaches for the Identification of Peptide Deformylase Inhibitors as Antibacterial Drugs
title_full Ligand and Structure-Based Approaches for the Identification of Peptide Deformylase Inhibitors as Antibacterial Drugs
title_fullStr Ligand and Structure-Based Approaches for the Identification of Peptide Deformylase Inhibitors as Antibacterial Drugs
title_full_unstemmed Ligand and Structure-Based Approaches for the Identification of Peptide Deformylase Inhibitors as Antibacterial Drugs
title_short Ligand and Structure-Based Approaches for the Identification of Peptide Deformylase Inhibitors as Antibacterial Drugs
title_sort ligand and structure-based approaches for the identification of peptide deformylase inhibitors as antibacterial drugs
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964514/
https://www.ncbi.nlm.nih.gov/pubmed/27428963
http://dx.doi.org/10.3390/ijms17071141
work_keys_str_mv AT gaojian ligandandstructurebasedapproachesfortheidentificationofpeptidedeformylaseinhibitorsasantibacterialdrugs
AT liangli ligandandstructurebasedapproachesfortheidentificationofpeptidedeformylaseinhibitorsasantibacterialdrugs
AT zhuyasheng ligandandstructurebasedapproachesfortheidentificationofpeptidedeformylaseinhibitorsasantibacterialdrugs
AT qiushengzhi ligandandstructurebasedapproachesfortheidentificationofpeptidedeformylaseinhibitorsasantibacterialdrugs
AT wangtao ligandandstructurebasedapproachesfortheidentificationofpeptidedeformylaseinhibitorsasantibacterialdrugs
AT zhangling ligandandstructurebasedapproachesfortheidentificationofpeptidedeformylaseinhibitorsasantibacterialdrugs